Recent corticosteroid use and recent disease activity: Independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
Open Access
- 31 January 2008
- journal article
- systemic lupus-erythematosus
- Published by Wiley in Arthritis Care & Research
- Vol. 59 (2), 169-175
- https://doi.org/10.1002/art.23352
Abstract
Objective Systemic lupus erythematosus (SLE) is characterized by a markedly elevated risk for coronary heart disease (CHD), the exact pathogenesis of which is unknown. In particular, the causal roles of corticosteroid therapy and SLE disease activity, and whether their putative effects are mediated through conventional risk factors, remain unclear. Methods Data abstracted retrospectively from the charts at 11,359 clinic visits for 310 patients with SLE to the Montreal General Hospital were used to investigate the associations of recent corticosteroid dose and recent Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score with 8 CHD risk factors (total serum cholesterol, high-density lipoprotein [HDL] cholesterol, low-density lipoprotein cholesterol, apolipoprotein B [Apo B], triglycerides, systolic blood pressure [BP], body mass index, and blood glucose) and the aggregate estimate of 2-year CHD risk. Separate multivariable linear regression models estimated the mutually-adjusted effects of average daily corticosteroid dose and average SLEDAI score within the past year on the current level of each risk factor while adjusting for age, sex, cumulative damage score, disease duration, and, where appropriate, use of relevant medications. Results Higher past-year corticosteroid dose was independently associated with significantly higher overall 2-year CHD risk and with higher levels of all 8 individual risk factors. Higher past-year lupus disease activity was independently associated with higher overall 2-year CHD risk, lower HDL cholesterol, and higher values of systolic BP, Apo B, triglycerides, and blood glucose. Conclusion In SLE, both recent use of corticosteroids and recent lupus activity are independently associated with higher values of several well-recognized CHD risk factors and overall 2-year CHD risk.Keywords
This publication has 44 references indexed in Scilit:
- Updated Risk Factor Values and the Ability of the Multivariable Risk Score to Predict Coronary Heart DiseaseAmerican Journal of Epidemiology, 2004
- Premature Coronary-Artery Atherosclerosis in Systemic Lupus ErythematosusNew England Journal of Medicine, 2003
- Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus ErythematosusNew England Journal of Medicine, 2003
- Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosusArthritis & Rheumatism, 2001
- Vascular Stiffness in Women With Systemic Lupus ErythematosusHypertension, 2001
- Vascular imaging: changing the face of cardiovascular research.Lupus, 2000
- Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysisAmerican Journal Of Medicine, 1994
- Elevated Apolipoprotein-B Levels in Corticosteroid-Treated Patients with Systemic Lupus Erythematosus*Journal of Clinical Endocrinology & Metabolism, 1988
- Dyslipoproteinemia in systemic lupus erythematosusAmerican Journal Of Medicine, 1987
- Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipidsAtherosclerosis, 1987